Italy vs Malta: Cause of death, by non-communicable diseases, ages 5-14
Italy
75.7%
in 2021
Malta
87.4%
in 2021
Italy rank
3rd
Malta rank
1st
Cause of death, by non-communicable diseases, ages 5-14 over time
- Italy
- Malta
How they compare
Malta currently reports 87.4% against 75.7% in Italy, a difference of 11.7%.
That makes Malta's figure about 1.2 times Italy's.
The two have swapped places 5 times across 6 shared years of data; in 2000 it was Italy ahead.
Italy ranks 3rd and Malta ranks 1st of 185 countries.
Across the 3 decades both report, Italy averaged higher in 1 and Malta in 2.
Head to head by decade
| Decade | Italy | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 67.2% | 53.6% | 13.6% | Italy |
| 2010s | 73.7% | 83.9% | 10.2% | Malta |
| 2020s | 75.6% | 80.9% | 5.3% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Italy or Malta?
- Malta, at 87.4% against 75.7% in Italy as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Italy and Malta?
- 11.7%, with Malta ahead.
- How many years of comparable data are there for Italy and Malta?
- 6 years are reported by both, from 2000 to 2021.
- How do Italy and Malta rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Italy ranks 3rd and Malta ranks 1st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.